Latest Articles

Article Type

You have access
Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database
NAOHITO IDE, KEN-ICHI SAKO and TOMOJI MAEDA

Anticancer Research May 2025, 45 (5) 2215-2223; DOI: https://doi.org/10.21873/anticanres.17595
You have access
Efficacy and Prognostic Factors of Surgical Resection for Pulmonary Metastases From Ovarian Cancer
YO TSUKAMOTO, TAKASHI OHTSUKA, YOSHIKANE YAMAUCHI, MINGYON MUN, HARUHISA MATSUGUMA, HIROSHI HASHIMOTO, HIROKI FUKUDA, ICHIRO YOSIHNO, YASUSHI SHINTANI and MASAFUMI KAWAMURA

Anticancer Research May 2025, 45 (5) 2071-2078; DOI: https://doi.org/10.21873/anticanres.17581
Open Access
Long-term Outcomes of Helical Tomotherapy in Lymph Node-positive Breast Cancer Following Breast-conserving Surgery
FELIX ZWICKER, LUIS-PHILIPP RAETHER, RUDOLF KLEPPER, HENRIK HAUSWALD, SEBASTIAN HOEFEL, PETER E. HUBER, JUERGEN DEBUS and MICHAEL SCHEMPP

Anticancer Research May 2025, 45 (5) 2025-2040; DOI: https://doi.org/10.21873/anticanres.17577
You have access
Prediction of Severe Anemia and Neutropenia Induced by Abemaciclib in Patients With Breast Cancer
SHINYA TAKADA, KENGO UMEHARA, TAHATSU KANAE, YUTA KIMURA, FUKAI YUTA, MITSUGU YAMAMOTO, NOBUMOTO TOMIOKA, KENICHI WATANABE and HASHISHITA HIROKAZU

Anticancer Research May 2025, 45 (5) 2171-2183; DOI: https://doi.org/10.21873/anticanres.17591
Open Access
Role of Stromal CD25+/CD8+ Lymphocyte Ratio in Patients With Grade 2-3 Cervical Intraepithelial Neoplasia (CIN 2-3): A Retrospective Single-center Study
ENRICO SIMONETTI, SABINA PISTOLESI, AMERIGO FERRARI, MATTEO DELLA ROSA, FEDERICA MEI, FEDERICO DI COCCO, FABIO TAPONECO, STEFANIA COSIO, ALESSANDRO BONUCCELLI, ANGIOLO GADDUCCI, TOMMASO SIMONCINI, PIETRO BOTTONE, ANTONIO GIUSEPPE NACCARATO and LAVINIA DOMENICI

Anticancer Research May 2025, 45 (5) 2041-2050; DOI: https://doi.org/10.21873/anticanres.17578
Open Access
Treatment Outcomes After Progression With Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma
NOBUKI FURUBAYASHI, MANABU MOCHIDA, ATSUHIRO KIJIMA, YUSHI FUJIMOTO, MOTONOBU NAKAMURA and TAKAHITO NEGISHI

Anticancer Research May 2025, 45 (5) 2185-2193; DOI: https://doi.org/10.21873/anticanres.17592
You have access
Epigallocatechin Gallate Induces miR-192/215 Suppression of EGR1 in Gastric Cancer
NAN ZHOU, YUAN YUAN, HUIJUAN LIN, JIAN WANG, HUAN LIN, HASSAN ASHKTORAB, DUANE SMOOT, ZHE JIN, SHUTONG ZHUANG and YING QIN

Anticancer Research May 2025, 45 (5) 1935-1951; DOI: https://doi.org/10.21873/anticanres.17571
Open Access
Two Scoring Tools to Estimate the Risk of Taxane-induced Peripheral Sensory Neuropathy (PNP) in Patients Irradiated for Non-metastatic Breast Cancer
DIRK RADES, TOBIAS BARTSCHT, ACHIM RODY and MARTIN BALLEGAARD

Anticancer Research May 2025, 45 (5) 2115-2121; DOI: https://doi.org/10.21873/anticanres.17586
Open Access
Expression of YAP1 and TAZ in Melanoma-, Bronchial- and Breast Carcinoma Brain Metastasis: Primary vs. Relapsed Tumors
JILL DICKE, LAURA HERO, SASKIA KUHL, ROLAND GOLDBRUNNER and MARCO TIMMER

Anticancer Research May 2025, 45 (5) 1807-1812; DOI: https://doi.org/10.21873/anticanres.17560
Open Access
Advantages and Disadvantages of Drug Combination Treatment: Riluzole, Metformin and Dexamethasone Effect on Glioblastoma Cell
JONATHAN KEUL, SWETLANA SPERLING, VEIT ROHDE and MILENA NINKOVIC

Anticancer Research May 2025, 45 (5) 1813-1823; DOI: https://doi.org/10.21873/anticanres.17561

Main menu

User menu

Search

Latest Articles

Pages